ONEMEDNET CORPORATION (ONMD) Operating Margin
- Operating margin · 12 months: Value -696.15%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -696.15% | Operating income / revenue. Period ending 2026-06-30. $-10.13M ÷ $1.46M × 100 ≈ -696.15% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -10.13M USD | Operating Income (Loss) |
| Revenue | 1.46M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 1.40M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-10.13M | $1.46M | (m) | $1.40M | (m) | -696.15% |
| 2026-03-31 | $-9.99M | $1.32M | (m) | $1.48M | (m) | -758.35% |
| 2025-12-31 | $-9.67M | $1.36M | (m) | $1.51M | (m) | -711.33% |
| 2025-09-30 | $-9.30M | $494.00K | (m) | $1.41M | (m) | -1882.79% |
| 2025-06-30 | $-9.40M | $459.00K | (m) | $1.39M | (m) | -2048.37% |
| 2025-03-31 | $-9.73M | $532.00K | (m) | $1.37M | (m) | -1828.57% |
| 2024-12-31 | $-9.61M | $643.00K | (m) | $1.47M | (m) | -1493.78% |
| 2024-09-30 | $-8.81M | $957.00K | (m) | $1.63M | (m) | -920.27% |
| 2024-06-30 | $-8.35M | $1.14M | (m) | $1.73M | (m) | -731.73% |
| 2024-03-31 | $-7.49M | $1.07M | (m) | $1.93M | (m) | -700.19% |
| 2023-12-31 | $-8.37M | $1.02M | (m) | $1.63M | (m) | -819.68% |
| 2023-09-30 | $-5.97M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $-4.54M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $-5.05M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-5.31M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |